{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "30",
                "@timestamp": "2023-08-30T04:37:52.000052-04:00",
                "@year": "2023",
                "@month": "08"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "03"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Merck Sharp & Dohme LLC",
                "xocs:funding-agency-acronym": "MSD",
                "xocs:funding-agency": "Merck Sharp and Dohme",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100009947",
                "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
            },
            "xocs:funding-addon-generated-timestamp": "2023-02-09T05:48:23.854Z",
            "xocs:funding-text": "The authors thank the participants and their families for participating in the study; all investigators and site personnel; and the following employees of MSD: Burak Gumuscu and Vicki Goodman for critical review of the manuscript, Joy Ge for statistical guidance, and Nadia Camille and Randal Bugianesi for clinical study support. Medical writing and/or editorial assistance was provided by Yue Liu of Merck & Co., Inc., Rahway, NJ, USA, and Jemimah Walker, PhD, and Doyel Mitra, PhD, CMPP, of ApotheCom (Yardley, PA, USA). This assistance was funded by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. , Rahway, NJ, USA.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "@afid": "60024787",
                            "@country": "hkg",
                            "city": "Hong Kong",
                            "organization": [
                                {"$": "State Key Laboratory in Translational Oncology"},
                                {"$": "Sir YK Pao Centre for Cancer"},
                                {"$": "The Chinese University of Hong Kong"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60024787",
                                    "@dptid": "121406678"
                                },
                                {"@afid": "60002798"}
                            ],
                            "@affiliation-instance-id": "S0923753422047779-944b92581bbc491480dd0a80cd722cce",
                            "ce:source-text": "State Key Laboratory in Translational Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong, China",
                            "@dptid": "121406678"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "A. T.C.",
                                "ce:initials": "A.T.C.",
                                "ce:surname": "Chan",
                                "ce:indexed-name": "Chan A.T.C."
                            },
                            "@author-instance-id": "S0923753422047779-870e8a72e0ef56f70d43a6c319ad406c",
                            "@seq": "1",
                            "ce:initials": "A.T.C.",
                            "@date-locked": "2023-08-29T15:31:43.311",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chan",
                            "@auid": "13404833700",
                            "ce:indexed-name": "Chan A.T.C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "@afid": "60006541",
                            "@country": "hkg",
                            "city": "Hong Kong",
                            "organization": [
                                {"$": "Department of Clinical Oncology"},
                                {"$": "The University of Hong Kong"}
                            ],
                            "affiliation-id": {
                                "@afid": "60006541",
                                "@dptid": "113916987"
                            },
                            "@affiliation-instance-id": "S0923753422047779-15e84c5c36a65ae2025f99989ecae007",
                            "ce:source-text": "Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China",
                            "@dptid": "113916987"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "V. H.F.",
                                "ce:initials": "V.H.F.",
                                "ce:surname": "Lee",
                                "ce:indexed-name": "Lee V.H.F."
                            },
                            "@author-instance-id": "S0923753422047779-2bdf7d70ae6b69dcbeaf412563b33940",
                            "@seq": "2",
                            "ce:initials": "V.H.F.",
                            "@date-locked": "2023-04-21T11:29:53.099",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lee",
                            "@auid": "57209197322",
                            "ce:indexed-name": "Lee V.H.F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60073385",
                            "@country": "twn",
                            "city": "Taipei",
                            "organization": {"$": "National Taiwan University Hospital"},
                            "affiliation-id": {"@afid": "60073385"},
                            "@affiliation-instance-id": "S0923753422047779-0d0712579196f1930d8255a61e88ee82",
                            "ce:source-text": "National Taiwan University Hospital, Taipei, Taiwan"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "R. L.",
                                "ce:initials": "R.L.",
                                "ce:surname": "Hong",
                                "ce:indexed-name": "Hong R.L."
                            },
                            "@author-instance-id": "S0923753422047779-d40760f5144e20957744cb5708896ffb",
                            "@seq": "3",
                            "ce:initials": "R.-L.",
                            "@date-locked": "2023-07-14T12:35:58.861",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Hong",
                            "@auid": "57223631236",
                            "ce:indexed-name": "Hong R.-L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60020857",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": {"$": "Samsung Medical Centre"},
                            "affiliation-id": {"@afid": "60020857"},
                            "@affiliation-instance-id": "S0923753422047779-260a2cce8e27bc0e3a413569f31cb933",
                            "ce:source-text": "Samsung Medical Centre, Seoul, South Korea"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "M. J.",
                                "ce:initials": "M.J.",
                                "ce:surname": "Ahn",
                                "ce:indexed-name": "Ahn M.J."
                            },
                            "@author-instance-id": "S0923753422047779-e291164ec3c8d23c69ba25dac0cbdaf6",
                            "@seq": "4",
                            "ce:initials": "M.-J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ahn",
                            "@auid": "7103352186",
                            "ce:indexed-name": "Ahn M.-J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "127780700",
                            "@country": "sgp",
                            "city": "Singapore",
                            "organization": {"$": "National University Cancer Institute"},
                            "affiliation-id": {"@afid": "127780700"},
                            "@affiliation-instance-id": "S0923753422047779-b5175e39a1009f70f50efbed94580f5f",
                            "ce:source-text": "National University Cancer Institute, Singapore, Singapore"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "W. Q.",
                                "ce:initials": "W.Q.",
                                "ce:surname": "Chong",
                                "ce:indexed-name": "Chong W.Q."
                            },
                            "@author-instance-id": "S0923753422047779-ee051161043de3c0bb98201815affd0d",
                            "@seq": "5",
                            "ce:initials": "W.Q.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chong",
                            "@auid": "57217144745",
                            "ce:indexed-name": "Chong W.Q."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60006240",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Asan Medical Centre"},
                                {"$": "University of Ulsan College of Medicine"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60006240"},
                                {"@afid": "60068691"}
                            ],
                            "@affiliation-instance-id": "S0923753422047779-b430ac9f1f7cc1ce0bef4287248324d3",
                            "ce:source-text": "Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "S. B.",
                                "ce:initials": "S.B.",
                                "ce:surname": "Kim",
                                "ce:indexed-name": "Kim S.B."
                            },
                            "@author-instance-id": "S0923753422047779-d0be4c47be0931e4d606e32c0a399915",
                            "@seq": "6",
                            "ce:initials": "S.-B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kim",
                            "@auid": "34770722200",
                            "ce:indexed-name": "Kim S.-B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60029157",
                            "@country": "mys",
                            "city": "Kuala Lumpur",
                            "organization": [
                                {"$": "Clinical Oncology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "University Malaya"}
                            ],
                            "affiliation-id": {
                                "@afid": "60029157",
                                "@dptid": "113756126"
                            },
                            "@affiliation-instance-id": "S0923753422047779-26f029c69b3bf6be516eea2193f1ac52",
                            "ce:source-text": "University Malaya, Kuala Lumpur, Malaysia",
                            "@dptid": "113756126"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "G. F.",
                                "ce:initials": "G.F.",
                                "ce:surname": "Ho",
                                "ce:indexed-name": "Ho G.F."
                            },
                            "@author-instance-id": "S0923753422047779-311a022cbcbcbdb13f82413149632d03",
                            "@seq": "7",
                            "ce:initials": "G.F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ho",
                            "@auid": "55009123200",
                            "ce:indexed-name": "Ho G.F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Philippines",
                            "@afid": "60071488",
                            "@country": "phl",
                            "city": "Manila",
                            "organization": [
                                {"$": "St. Luke's Medical Center"},
                                {"$": "University of Santo Tomas Faculty of Medicine and Surgery"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60071488"},
                                {"@afid": "60071484"}
                            ],
                            "@affiliation-instance-id": "S0923753422047779-faaa8ccaaae7e4e842eba63d6fb66e23",
                            "ce:source-text": "St. Luke's Medical Center, University of Santo Tomas Faculty of Medicine and Surgery, Manila, Philippines"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "P. B.",
                                "ce:initials": "P.B.",
                                "ce:surname": "Caguioa",
                                "ce:indexed-name": "Caguioa P.B."
                            },
                            "@author-instance-id": "S0923753422047779-cd2c786c6cd39eaf2f012df46a93fc47",
                            "@seq": "8",
                            "ce:initials": "P.B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Caguioa",
                            "@auid": "6506598676",
                            "ce:indexed-name": "Caguioa P.B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60199578"},
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "S0923753422047779-4726fac142d9f13ca00c046c2dda01bb",
                            "ce:source-text": "Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "N.",
                                "ce:initials": "N.",
                                "ce:surname": "Ngamphaiboon",
                                "ce:indexed-name": "Ngamphaiboon N."
                            },
                            "@author-instance-id": "S0923753422047779-83c7add1dff7ed4acd96e2f8fe04ac2d",
                            "@seq": "9",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ngamphaiboon",
                            "@auid": "35435598900",
                            "ce:indexed-name": "Ngamphaiboon N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Canada",
                            "@afid": "60010365",
                            "@country": "can",
                            "city": "Vancouver",
                            "organization": [
                                {"$": "BC Cancer"},
                                {"$": "University of British Columbia"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60010365"},
                                {"@afid": "60028379"}
                            ],
                            "@affiliation-instance-id": "S0923753422047779-2e711fa01af8578d619d8b0d17d066a2",
                            "ce:source-text": "BC Cancer Research, University of British Columbia, Vancouver, Canada"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "C.",
                                "ce:initials": "C.",
                                "ce:surname": "Ho",
                                "ce:indexed-name": "Ho C."
                            },
                            "@author-instance-id": "S0923753422047779-9926e72e3cfc62c89a0d24631bd02a84",
                            "@seq": "10",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ho",
                            "@auid": "57984513700",
                            "ce:indexed-name": "Ho C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60010400",
                            "@country": "mys",
                            "city": "Penang",
                            "organization": [
                                {"$": "Gleneagles Penang Clinical Research Center"},
                                {"$": "Gleneagles Hospital Penang"}
                            ],
                            "affiliation-id": {"@afid": "60010400"},
                            "@affiliation-instance-id": "S0923753422047779-f0270dafba0570d094bc28e75fa85914",
                            "ce:source-text": "Gleneagles Penang Clinical Research Center, Gleneagles Hospital Penang, Penang, Malaysia"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "M. A.S.A.",
                                "ce:initials": "M.A.S.A.",
                                "ce:surname": "Aziz",
                                "ce:indexed-name": "Aziz M.A.S.A."
                            },
                            "@author-instance-id": "S0923753422047779-fff17b38725450caed88d4b24c7a89be",
                            "@seq": "11",
                            "ce:initials": "M.A.S.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Aziz",
                            "@auid": "58090215100",
                            "ce:indexed-name": "Aziz M.A.S.A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60031809",
                            "@country": "sgp",
                            "city": "Singapore",
                            "organization": {"$": "National Cancer Centre Singapore"},
                            "affiliation-id": {"@afid": "60031809"},
                            "@affiliation-instance-id": "S0923753422047779-dd978cb203cfb2b36400aa5b728bd818",
                            "ce:source-text": "National Cancer Centre Singapore, Singapore, Singapore"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "Q. S.",
                                "ce:initials": "Q.S.",
                                "ce:surname": "Ng",
                                "ce:indexed-name": "Ng Q.S."
                            },
                            "@author-instance-id": "S0923753422047779-922f33421b13555451ef28d52161f584",
                            "@seq": "12",
                            "ce:initials": "Q.S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ng",
                            "@auid": "13104423000",
                            "ce:indexed-name": "Ng Q.S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60073386",
                            "@country": "twn",
                            "city": "Tainan",
                            "organization": [
                                {"$": "National Cheng Kung University Hospital"},
                                {"$": "College of Medicine"},
                                {"$": "National Cheng Kung University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60073386"},
                                {"@afid": "60003394"},
                                {"@afid": "60014982"}
                            ],
                            "@affiliation-instance-id": "S0923753422047779-94e64baf723e1601a1a9327ee9d23cb8",
                            "ce:source-text": "National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "C. J.",
                                "ce:initials": "C.J.",
                                "ce:surname": "Yen",
                                "ce:indexed-name": "Yen C.J."
                            },
                            "@author-instance-id": "S0923753422047779-6742bdfdccbd3cb4435be8069274414c",
                            "@seq": "13",
                            "ce:initials": "C.-J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yen",
                            "@auid": "58089961000",
                            "ce:indexed-name": "Yen C.-J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199575",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Faculty of Medicine Siriraj Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199575",
                                    "@dptid": "125771106"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "S0923753422047779-02144b77ac2ea59b501a8c0cca32f0fb",
                            "ce:source-text": "Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125771106"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "N.",
                                "ce:initials": "N.",
                                "ce:surname": "Soparattanapaisarn",
                                "ce:indexed-name": "Soparattanapaisarn N."
                            },
                            "@author-instance-id": "S0923753422047779-40519ebbeb721816555d917dee17cf85",
                            "@seq": "14",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Soparattanapaisarn",
                            "@auid": "37102561700",
                            "ce:indexed-name": "Soparattanapaisarn N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "@afid": "60014234",
                            "@country": "hkg",
                            "city": "Hong Kong",
                            "organization": [
                                {"$": "Queen Elizabeth Hospital"},
                                {"$": "Kowloon"}
                            ],
                            "affiliation-id": {"@afid": "60014234"},
                            "@affiliation-instance-id": "S0923753422047779-f7b7760cafa02ee6d0baf21779eb9acf",
                            "ce:source-text": "Queen Elizabeth Hospital, Kowloon, Hong Kong, China"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "R. K.C.",
                                "ce:initials": "R.K.C.",
                                "ce:surname": "Ngan",
                                "ce:indexed-name": "Ngan R.K.C."
                            },
                            "@author-instance-id": "S0923753422047779-fe12f33bbfa55ed39da275645dfaee99",
                            "@seq": "15",
                            "ce:initials": "R.K.-C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ngan",
                            "@auid": "57222641833",
                            "ce:indexed-name": "Ngan R.K.-C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60090650",
                            "@country": "mys",
                            "city": "Kuching",
                            "organization": {"$": "Hospital Umum Sarawak"},
                            "affiliation-id": {"@afid": "60090650"},
                            "@affiliation-instance-id": "S0923753422047779-7d7f32e19c3d5226ae20da41deff88a4",
                            "ce:source-text": "Hospital Umum Sarawak, Kuching, Malaysia"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "S. K.",
                                "ce:initials": "S.K.",
                                "ce:surname": "Kho",
                                "ce:indexed-name": "Kho S.K."
                            },
                            "@author-instance-id": "S0923753422047779-e03df4a184e6fd110ab292e04ac20b02",
                            "@seq": "16",
                            "ce:initials": "S.K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kho",
                            "@auid": "57221906319",
                            "ce:indexed-name": "Kho S.K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Philippines",
                            "@afid": "126186367",
                            "@country": "phl",
                            "city": "San Juan City",
                            "organization": {"$": "Cardinal Santos Medical Center"},
                            "affiliation-id": {"@afid": "126186367"},
                            "@affiliation-instance-id": "S0923753422047779-5d2c19e5b30a9ea140b55e2f992a05af",
                            "ce:source-text": "Cardinal Santos Medical Center, San Juan City, Philippines"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "M. L.A.",
                                "ce:initials": "M.L.A.",
                                "ce:surname": "Tiambeng",
                                "ce:indexed-name": "Tiambeng M.L.A."
                            },
                            "@author-instance-id": "S0923753422047779-34af11eb9ca147556a38d487f4d5003a",
                            "@seq": "17",
                            "ce:initials": "M.L.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tiambeng",
                            "@auid": "57193519025",
                            "ce:indexed-name": "Tiambeng M.L.A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60068716",
                            "@country": "kor",
                            "city": "Goyang-si",
                            "organization": {"$": "National Cancer Center"},
                            "affiliation-id": {"@afid": "60068716"},
                            "@affiliation-instance-id": "S0923753422047779-b45156536265b294f533adfe164a0406",
                            "ce:source-text": "National Cancer Center, Goyang-si, South Korea"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "T.",
                                "ce:initials": "T.",
                                "ce:surname": "Yun",
                                "ce:indexed-name": "Yun T."
                            },
                            "@author-instance-id": "S0923753422047779-2c517cba1df21ee935162a6fac7119a5",
                            "@seq": "18",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yun",
                            "@auid": "7005281991",
                            "ce:indexed-name": "Yun T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": {"$": "Chulalongkorn University and the King Chulalongkorn Memorial Hospital"},
                            "affiliation-id": [
                                {"@afid": "60022183"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "S0923753422047779-de0f109f2e23e4b84b69090150fc48c6",
                            "ce:source-text": "Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, Thailand"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "V.",
                                "ce:initials": "V.",
                                "ce:surname": "Sriuranpong",
                                "ce:indexed-name": "Sriuranpong V."
                            },
                            "@author-instance-id": "S0923753422047779-3fd7ea25122fd1823caee6a7edba0af6",
                            "@seq": "19",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sriuranpong",
                            "@auid": "6603599644",
                            "ce:indexed-name": "Sriuranpong V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60023691",
                            "@country": "usa",
                            "city": "San Francisco",
                            "organization": {"$": "UCSF"},
                            "affiliation-id": {"@afid": "60023691"},
                            "@affiliation-instance-id": "S0923753422047779-f048b565bd17dec60be8d17093d6c20a",
                            "ce:source-text": "UCSF, San Francisco, USA"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "A. P.",
                                "ce:initials": "A.P.",
                                "ce:surname": "Algazi",
                                "ce:indexed-name": "Algazi A.P."
                            },
                            "@author-instance-id": "S0923753422047779-a05b2f07d025f0c7d540097490b46b71",
                            "@seq": "20",
                            "ce:initials": "A.P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Algazi",
                            "@auid": "36943945300",
                            "ce:indexed-name": "Algazi A.P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "@afid": "60013108",
                            "@country": "hkg",
                            "city": "Hong Kong",
                            "organization": {"$": "Princess Margaret Hospital"},
                            "affiliation-id": {"@afid": "60013108"},
                            "@affiliation-instance-id": "S0923753422047779-6f892fb25608a55586a1e84b6e7e74c6",
                            "ce:source-text": "Princess Margaret Hospital, Hong Kong, China"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "A.",
                                "ce:initials": "A.",
                                "ce:surname": "Cheng",
                                "ce:indexed-name": "Cheng A."
                            },
                            "@author-instance-id": "S0923753422047779-14a4de644ad93e4e5bd3effc99be9332",
                            "@seq": "21",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Cheng",
                            "@auid": "36055097300",
                            "ce:indexed-name": "Cheng A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60007474",
                            "@country": "usa",
                            "city": "Duarte",
                            "organization": {"$": "City of Hope Comprehensive Cancer Center"},
                            "affiliation-id": {"@afid": "60007474"},
                            "@affiliation-instance-id": "S0923753422047779-610f1c8041272a711ddaa20f95f75e52",
                            "ce:source-text": "City of Hope Comprehensive Cancer Center, Duarte, USA"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "E.",
                                "ce:initials": "E.",
                                "ce:surname": "Massarelli",
                                "ce:indexed-name": "Massarelli E."
                            },
                            "@author-instance-id": "S0923753422047779-5d2fb346f60549bc9c8474e771fb94c9",
                            "@seq": "22",
                            "ce:initials": "E.",
                            "@date-locked": "2023-06-02T12:17:49.472",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Massarelli",
                            "@auid": "6602382732",
                            "ce:indexed-name": "Massarelli E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60007995",
                            "@country": "usa",
                            "city": "Rahway",
                            "organization": [
                                {"$": "Merck & Co."},
                                {"$": "Inc."}
                            ],
                            "affiliation-id": {"@afid": "60007995"},
                            "@affiliation-instance-id": "S0923753422047779-b6d1fda7e60c57402aa740d03a9c5753",
                            "ce:source-text": "Merck & Co., Inc., Rahway, USA"
                        },
                        "author": [
                            {
                                "preferred-name": {
                                    "ce:given-name": "R. F.",
                                    "ce:initials": "R.F.",
                                    "ce:surname": "Swaby",
                                    "ce:indexed-name": "Swaby R.F."
                                },
                                "@author-instance-id": "S0923753422047779-2dc09a06d26d65fb850b2025ea6b2411",
                                "@seq": "23",
                                "ce:initials": "R.F.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Swaby",
                                "@auid": "8908060000",
                                "ce:indexed-name": "Swaby R.F."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "S.",
                                    "ce:initials": "S.",
                                    "ce:surname": "Saraf",
                                    "ce:indexed-name": "Saraf S."
                                },
                                "@author-instance-id": "S0923753422047779-813dcad0799a8f2dd280974fbfbe316a",
                                "@seq": "24",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Saraf",
                                "@auid": "57192942563",
                                "ce:indexed-name": "Saraf S."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "J.",
                                    "ce:initials": "J.",
                                    "ce:surname": "Yuan",
                                    "ce:indexed-name": "Yuan J."
                                },
                                "@author-instance-id": "S0923753422047779-dd4ffa1c0f91f5ffa11cdf494a0922ce",
                                "@seq": "25",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Yuan",
                                "@auid": "58089961300",
                                "ce:indexed-name": "Yuan J."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Canada",
                            "@afid": "60016849",
                            "@country": "can",
                            "city": "Toronto",
                            "organization": [
                                {"$": "Princess Margaret Cancer Centre"},
                                {"$": "University of Toronto"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60016849"},
                                {"@afid": "60027817"}
                            ],
                            "@affiliation-instance-id": "S0923753422047779-f0db27c09e724530118d7659627c2a2e",
                            "ce:source-text": "Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "L. L.",
                                "ce:initials": "L.L.",
                                "ce:surname": "Siu",
                                "ce:indexed-name": "Siu L.L."
                            },
                            "@author-instance-id": "S0923753422047779-4257a357b2c19ad7e20f987a998443a7",
                            "@seq": "26",
                            "ce:initials": "L.L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Siu",
                            "@auid": "7006651151",
                            "ce:indexed-name": "Siu L.L."
                        }]
                    }
                ],
                "citation-title": "Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial",
                "abstracts": "© 2023 Merck Sharp & Dohme LLC., a subsidiary Merck & Co., Inc., The Author(s).Background: Pembrolizumab previously demonstrated robust antitumor activity and manageable safety in a phase Ib study of patients with heavily pretreated, programmed death ligand 1 (PD-L1)-positive, recurrent or metastatic nasopharyngeal carcinoma (NPC). The phase III KEYNOTE-122 study was conducted to further evaluate pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent and/or metastatic NPC. Final analysis results are presented. Patients and methods: KEYNOTE-122 was an open-label, randomized study conducted at 29 sites, globally. Participants with platinum-pretreated recurrent and/or metastatic NPC were randomly assigned (1 : 1) to pembrolizumab or chemotherapy with capecitabine, gemcitabine, or docetaxel. Randomization was stratified by liver metastasis (present versus absent). The primary endpoint was overall survival (OS), analyzed in the intention-to-treat population using the stratified log-rank test (superiority threshold, one-sided P = 0.0187). Safety was assessed in the as-treated population. Results: Between 5 May 2016 and 28 May 2018, 233 participants were randomly assigned to treatment (pembrolizumab, n = 117; chemotherapy, n = 116); Most participants (86.7%) received study treatment in the second-line or later setting. Median time from randomization to data cut-off (30 November 2020) was 45.1 months (interquartile range, 39.0-48.8 months). Median OS was 17.2 months [95% confidence interval (CI) 11.7-22.9 months] with pembrolizumab and 15.3 months (95% CI 10.9-18.1 months) with chemotherapy [hazard ratio, 0.90 (95% CI 0.67-1.19; P = 0.2262)]. Grade 3-5 treatment-related adverse events occurred in 12 of 116 participants (10.3%) with pembrolizumab and 49 of 112 participants (43.8%) with chemotherapy. Three treatment-related deaths occurred: 1 participant (0.9%) with pembrolizumab (pneumonitis) and 2 (1.8%) with chemotherapy (pneumonia, intracranial hemorrhage). Conclusion: Pembrolizumab did not significantly improve OS compared with chemotherapy in participants with platinum-pretreated recurrent and/or metastatic NPC but did have manageable safety and a lower incidence of treatment-related adverse events.",
                "correspondence": {
                    "affiliation": {
                        "country": "Hong Kong",
                        "@country": "hkg",
                        "city": "Hong Kong",
                        "organization": [
                            {"$": "State Key Laboratory in Translational Oncology"},
                            {"$": "Sir YK Pao Centre for Cancer"},
                            {"$": "The Chinese University of Hong Kong"}
                        ]
                    },
                    "person": {
                        "ce:initials": "A.T.C.",
                        "ce:surname": "Chan",
                        "ce:indexed-name": "Chan A.T.C."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "immunotherapy",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "nasopharyngeal cancer",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "pembrolizumab",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "programmed death-1 (PD-1)",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://www.journals.elsevier.com/annals-of-oncology",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Annals of Oncology",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "34",
                            "@issue": "3"
                        },
                        "pagerange": {
                            "@first": "251",
                            "@last": "261"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Annals of Oncology",
                    "publicationdate": {
                        "month": "03",
                        "year": "2023",
                        "date-text": "March 2023",
                        "day": "01"
                    },
                    "codencode": "ANONE",
                    "sourcetitle-abbrev": "Ann. Oncol.",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "15698041",
                            "@type": "electronic"
                        },
                        {
                            "$": "09237534",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "Elsevier Ltd"},
                    "@srcid": "28711"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "11",
                                    "classification-description": "Otorhinolaryngology"
                                },
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2720"},
                                {"$": "2730"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "154361-50-9",
                                    "chemical-name": "capecitabine"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "19230-81-0"},
                                        {"$": "60-27-5"}
                                    ],
                                    "chemical-name": "creatinine"
                                },
                                {
                                    "cas-registry-number": "114977-28-5",
                                    "chemical-name": "docetaxel"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "103882-84-4"},
                                        {"$": "95058-81-4"}
                                    ],
                                    "chemical-name": "gemcitabine"
                                },
                                {
                                    "cas-registry-number": "1374853-91-4",
                                    "chemical-name": "pembrolizumab"
                                },
                                {
                                    "cas-registry-number": "7440-06-4",
                                    "chemical-name": "platinum"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antibodies, Monoclonal, Humanized"},
                                {"chemical-name": "Docetaxel"},
                                {"chemical-name": "pembrolizumab"},
                                {"chemical-name": "Platinum"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The authors thank the participants and their families for participating in the study; all investigators and site personnel; and the following employees of MSD: Burak Gumuscu and Vicki Goodman for critical review of the manuscript, Joy Ge for statistical guidance, and Nadia Camille and Randal Bugianesi for clinical study support. Medical writing and/or editorial assistance was provided by Yue Liu of Merck & Co. Inc. Rahway, NJ, USA, and Jemimah Walker, PhD, and Doyel Mitra, PhD, CMPP, of ApotheCom (Yardley, PA, USA). This assistance was funded by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc., Rahway, NJ, USA. This work was supported by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc., Rahway, NJ, USA (no grant number). ATCC had received honoraria from Beigene, Springer, Merck, and Pfizer; advisory/consulting fees from Merck Serono, Cullinan Management Inc. Tessa Therapeutics, and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc. Rahway, NJ, USA (MSD); research grants/funding to their institution from Merck Serono, MSD, Novartis, Pfizer, and Eli Lilly; support for travel/accommodations/expenses from Bristol Myers Squibb (BMS), MSD, Pfizer, Roche, Novartis, and AstraZeneca; full/part-time employment at The Chinese University of Hong Kong; and reports non-remunerated activities with Immunomic Therapeutics, Inc. Angene Biotechnology, and Owlstone Medical Limited. VHFL has received honoraria from Amgen, AstraZeneca, Boston Scientific, Eli Lilly, MSD, Novartis, Pfizer, and Takeda; advisory/consultancy and speaker bureau fees from AQUILAB, AstraZeneca, and Merck; and research grant/funding from AstraZeneca and Roche. RLH received support to their institution from MSD for conduct of the clinical trial during the preparation of the submitted work and grants or contracts to the institution from MSD outside the submitted work. MJA has received honoraria from AstraZeneca, Takeda, MSD, ONO, BMS, Lilly, Amgen, Merck, and Roche; advisory/consultancy fees from AstraZeneca, Takeda, MSD, ONO, BMS, Lilly, Amgen, Merck, Roche, and Alpha Pharmaceuticals; and research grant/funding to their institution from AstraZeneca and Roche. WQC has received support for travel/accommodations/expenses from Amgen and MSD. SBK received support to their institution from MSD for conduct of the clinical trial during the preparation of the submitted work; and grants or contracts to their institution from Novartis, Sanofi-Aventis, and DongKook Pharm Co; consulting fees from Novartis, AstraZeneca, Lilly, DaeHwa Pharmaceutical Co, Ltd, ISU Abix, and Daiichi-Sankyo; and stock or stock options from Genopeaks and Neogene TC outside the submitted work. GFH has received grants to their institution from MSD during the conduct of the study; and has received grants or contracts to their institution from MSD, AstraZeneca, Eli Lilly, Arcus Biosciences, Inc. Pfizer, INEX EpiTherapeutics Pte. Ltd. Roche, Astellas, Novartis, Tessa Therapeutics, Regeneron, and Samsung Bioepis; honoraria/speaker bureau fees from Eli Lilly, Merck, and Pfizer; support for attending meetings and/or travel from AstraZeneca and BMS Pte Ltd; and has participated in data safety monitoring board or advisory board for Pfizer, Boehringer Ingelheim, AstraZeneca, MIMS, MSD, and Eli Lilly outside the submitted work. PBC received support to their institution from MSD for conduct of the clinical trial during the preparation of the submitted work and honoraria from Roche, Novartis, AstraZeneca, and MSD outside the submitted work. NN has received grants to their institution from MSD during the conduct of the study; has received grants to their institution from MSD, Roche, Exelixis, RAPT Therapeutics, BeiGene, and Pfizer; has received honoraria from Roche, AstraZeneca, Amgen, MSD, and Taiho; and has participated in advisory boards for MSD, Amgen, Novartis, Bayer, AstraZeneca, Claris, and Eli Lilly outside the submitted work. CH received honoraria from AstraZeneca, BMS, Boehringer Ingelheim, Bayer, Eisai, EMD Serono, Merck, Novartis, and Roche; research grants from AstraZeneca, MSD, and Roche; and other support for travel from Roche. QSN received support to their institution from MSD for conduct of the clinical trial during the preparation of the submitted work; received support for attending meetings and/or travel from MSD; and participated in an advisory board for MSD outside the submitted work. CJY received support to their institution from MSD for conduct of the clinical trial during the preparation of the submitted work. NS received support to their institution from MSD for conduct of the clinical trial during the preparation of the submitted work and honoraria from MSD, AstraZeneca, Roche, and BMS outside the submitted work. RKCN has received advisory/consulting fees from Pfizer, Novartis, Sanofi, AstraZeneca, Lilly, MSD, Zai Lab, Roche, and Eisai; speaker bureau fees from Novartis, AstraZeneca, Sanofi, Pfizer, Zai Lab, Eisai, Lilly, and MSD; research grant/funding to their institution from Pfizer; and support for travel/accommodations/expenses from Pfizer, Astellas, Novartis, MSD, Roche, Eisai, Merck, Sanofi, BMS, and Zai Lab. MLAT has received honoraria, speaker bureau, and advisory/consultancy fees from MSD. VS has received honoraria from AstraZeneca, Novartis, Eisai, Taiho, MSD, BMS, Pfizer, and Amgen; advisory/consultancy fees from AstraZeneca, Novartis, MSD, BMS, and Amgen; and research grant/funding from AstraZeneca, Novartis, MSD, Regeneron, and Roche. APA has received honoraria from OncoSec Medical, Inc.; advisory/consultancy fees from OncoSec and Valitor; research grant/funding to their institution from Merck, BMS, Acerta, Sensei, AstraZeneca, Incyte, Regeneron, Tessa, Lilly, Checkmate, and Idera; support for travel/accommodations/expenses from Sensei and OncoSec; is a shareholder/stock/holder/has stock options in OncoSec and Valitor; and reports non-remunerated activities with Sensei, Regeneron, and Sanofi. EM received honoraria from AstraZeneca and Merck; advisory/consultancy fees from Merck, BMS, Sanofi, Genentech, Lilly, and Janssen; speaker bureau fees from AstraZeneca, Takeda, Merck, and Lilly; research grant/funding to their institution from Pfizer, GSK, Merck, Tessa, AstraZeneca, BMS, and Genentech; and support for travel/accommodations/expenses from BMS, Pfizer, Merck, AstraZeneca, and Genentech. RFS was an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc. Rahway, NJ, USA, during the time of the conduct of the study and is currently an employee of Prelude Therapeutics. SS is an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc. Rahway, NJ, USA, and owns stock in Merck & Co. Inc. Rahway, NJ, USA. JY is an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc. Rahway, NJ, USA. LLS received support to their institution from MSD for conduct of the clinical trial and consulting/advisory board fees during the preparation of the submitted work; grants or contracts to their institution from Novartis, BMS, Pfizer, Boehringer Ingelheim, GSK, Roche/Genentech, Karyopharm, AstraZeneca, Astellas, Bayer, AbbVie, Amgen, Symphogen, Intensity Therapeutics, Mirati, Shattuck, and Avid; consulting fees from Pfizer, Celgene, AstraZeneca, MorphoSys, Roche, Oncorus, Symphogen, Seattle Genetics, GSK, Voronoi, Treadwell Therapeutics, Arvinas, Tessa, Navire, Relay, Rubius, Janpix, and Daiichi Sankyo; and their spouse is cofounder of Treadwell Therapeutics and owns stock in Agios outside the submitted work. All other authors have declared no conflicts of interest. Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc. Rahway, NJ, USA (MSD), is committed to providing qualified scientific researchers access to anonymized data and clinical study reports from the company's clinical trials for the purpose of conducting legitimate scientific research. MSD is also obligated to protect the rights and privacy of trial participants and, as such, has a procedure in place for evaluating and fulfilling requests for sharing company clinical trial data with qualified external scientific researchers. The MSD data sharing website (available at: http://engagezone.msd.com/ds_documentation.php) outlines the process and requirements for submitting a data request. Applications will be promptly assessed for completeness and policy compliance. Feasible requests will be reviewed by a committee of MSD subject matter experts to assess the scientific validity of the request and the qualifications of the requestors. In line with data privacy legislation, submitters of approved requests must enter into a standard data-sharing agreement with MSD before data access is granted. Data will be made available for request after product approval in the United States and EU or after product development is discontinued. There are circumstances that may prevent MSD from sharing requested data, including country or region-specific regulations. If the request is declined, it will be communicated to the investigator. Access to genetic or exploratory biomarker data requires a detailed, hypothesis-driven statistical analysis plan that is collaboratively developed by the requestor and MSD subject matter experts; after approval of the statistical analysis plan and execution of a data-sharing agreement, MSD will either perform the proposed analyses and share the results with the requestor or will construct biomarker covariates and add them to a file with clinical data that is uploaded to an analysis portal so that the requestor can perform the proposed analyses.",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-acronym": "MSD",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Merck Sharp and Dohme"
                            },
                            "grant-agency-id": "100009947"
                        },
                        {
                            "grant-acronym": "MSD",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Merck Sharp and Dohme"
                            },
                            "grant-agency-id": "100009947"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "11",
                    "@timestamp": "BST 04:23:06",
                    "@year": "2023",
                    "@month": "03"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2022325801",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "639819503",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "945860245",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230106278",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "36535566",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20230344573",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20230448704",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85147365199",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85147365199",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "639819503",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76776899",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S0923753422047779",
                    "ce:ern": "pii:S0923753422047779",
                    "ce:doi": "10.1016/j.annonc.2022.12.007"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "24",
                "reference": [
                    {
                        "ref-fulltext": "Wong, K.C.W., Hui, E.P., Lo, K.W., et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol 18 (2021), 679\u2013695.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Nasopharyngeal carcinoma: an evolving paradigm"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85113405406",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "679",
                                    "@last": "695"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.C.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong K.C.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Hui",
                                        "ce:indexed-name": "Hui E.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Lo",
                                        "ce:indexed-name": "Lo K.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Rev Clin Oncol"
                        },
                        "ce:source-text": "Wong KCW, Hui EP, Lo KW, et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol. 2021;18:679-695."
                    },
                    {
                        "ref-fulltext": "Chen, Y.P., Chan, A.T.C., Le, Q.T., et al. Nasopharyngeal carcinoma. Lancet 394:10192 (2019), 64\u201380.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Nasopharyngeal carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85068256399",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "394",
                                    "@issue": "10192"
                                },
                                "pagerange": {
                                    "@first": "64",
                                    "@last": "80"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen Y.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.T.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan A.T.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Q.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Le",
                                        "ce:indexed-name": "Le Q.T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64-80."
                    },
                    {
                        "ref-fulltext": "Sung, H., Ferlay, J., Siegel, R.L., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:3 (2021), 209\u2013249.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100345654",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "249"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Sung",
                                        "ce:indexed-name": "Sung H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ferlay",
                                        "ce:indexed-name": "Ferlay J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Siegel",
                                        "ce:indexed-name": "Siegel R.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "CA Cancer J Clin"
                        },
                        "ce:source-text": "Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249."
                    },
                    {
                        "ref-fulltext": "Bossi, P., Chan, A.T., Licitra, L., et al. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32:4 (2021), 452\u2013465.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100683380",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "32",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "452",
                                    "@last": "465"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Bossi",
                                        "ce:indexed-name": "Bossi P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan A.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Licitra",
                                        "ce:indexed-name": "Licitra L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Bossi P, Chan AT, Licitra L, et al. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(4):452-465."
                    },
                    {
                        "ref-fulltext": "Lang, J., Hu, C., Lu, T., et al. Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives. Cancer Manag Res 11 (2019), 6365\u20136376.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85070057571",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "6365",
                                    "@last": "6376"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lang",
                                        "ce:indexed-name": "Lang J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Hu",
                                        "ce:indexed-name": "Hu C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Manag Res"
                        },
                        "ce:source-text": "Lang J, Hu C, Lu T, et al. Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives. Cancer Manag Res. 2019;11:6365-6376."
                    },
                    {
                        "ref-fulltext": "National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers. Version 1.2022. 2022. 2021, National Comprehensive Cancer Network, Plymouth Meeting, PA.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers. Version 1.2022. 2022"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85107955262",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "National Comprehensive Cancer Network Plymouth Meeting, PA",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "National Comprehensive Cancer Network",
                                "ce:indexed-name": "National Comprehensive Cancer Network"
                            }}
                        },
                        "ce:source-text": "National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers. Version 1.2022. 2022. Plymouth Meeting, PA: National Comprehensive Cancer Network; 2021."
                    },
                    {
                        "ref-fulltext": "Liu, G.Y., Li, W.Z., Wang, D.S., et al. Capecitabine maintenance therapy after induction chemotherapy in newly diagnosed metastatic nasopharyngeal carcinoma: an open-label, randomized, controlled, phase trial. J Clin Oncol, 39(suppl 15), 2021 6044.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Capecitabine maintenance therapy after induction chemotherapy in newly diagnosed metastatic nasopharyngeal carcinoma: an open-label, randomized, controlled, phase trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85114018626",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "39"}},
                            "ref-text": "6044",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu G.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li W.Z."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang D.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Liu GY, Li WZ, Wang DS, et al. Capecitabine maintenance therapy after induction chemotherapy in newly diagnosed metastatic nasopharyngeal carcinoma: an open-label, randomized, controlled, phase trial. J Clin Oncol. 2021;39(suppl 15):6044-6044."
                    },
                    {
                        "ref-fulltext": "Masterson, L., Howard, J., Gonzalez-Cruz, J., et al. Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: beyond an era of chemoradiation?. Int J Cancer 146:8 (2020), 2305\u20132314.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: beyond an era of chemoradiation?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85078758340",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "146",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "2305",
                                    "@last": "2314"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Masterson",
                                        "ce:indexed-name": "Masterson L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Howard",
                                        "ce:indexed-name": "Howard J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gonzalez-Cruz",
                                        "ce:indexed-name": "Gonzalez-Cruz J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Cancer"
                        },
                        "ce:source-text": "Masterson L, Howard J, Gonzalez-Cruz J, et al. Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: beyond an era of chemoradiation? Int J Cancer. 2020;146(8):2305-2314."
                    },
                    {
                        "ref-fulltext": "Fang, W., Zhang, J., Hong, S., et al. EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy. Oncotarget 5:23 (2014), 12189\u201312202.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84920031403",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "5",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "12189",
                                    "@last": "12202"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Fang",
                                        "ce:indexed-name": "Fang W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Hong",
                                        "ce:indexed-name": "Hong S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Fang W, Zhang J, Hong S, et al. EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy. Oncotarget. 2014;5(23):12189-12202."
                    },
                    {
                        "ref-fulltext": "Johnson, D., Ma, B.B.Y., Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma. Oral Oncol, 113, 2021, 105127.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "105127",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85100166001",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "113"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Johnson",
                                    "ce:indexed-name": "Johnson D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.B.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Ma",
                                    "ce:indexed-name": "Ma B.B.Y."
                                }
                            ]},
                            "ref-sourcetitle": "Oral Oncol"
                        },
                        "ce:source-text": "Johnson D, Ma BBY. Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma. Oral Oncol. 2021;113:105127."
                    },
                    {
                        "ref-fulltext": "Hsu, C., Lee, S.H., Ejadi, S., et al. Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: results of the KEYNOTE-028 study. J Clin Oncol 35:36 (2017), 4050\u20134056.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: results of the KEYNOTE-028 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85038381568",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "35",
                                    "@issue": "36"
                                },
                                "pagerange": {
                                    "@first": "4050",
                                    "@last": "4056"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Hsu",
                                        "ce:indexed-name": "Hsu C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee S.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ejadi",
                                        "ce:indexed-name": "Ejadi S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Hsu C, Lee SH, Ejadi S, et al. Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: results of the KEYNOTE-028 study. J Clin Oncol. 2017;35(36):4050-4056."
                    },
                    {
                        "ref-fulltext": "Ma, B.B.Y., Lim, W.T., Goh, B.C., et al. Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the Mayo Clinic Phase 2 Consortium (NCI-9742). J Clin Oncol 36:14 (2018), 1412\u20131418.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the Mayo Clinic Phase 2 Consortium (NCI-9742)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85047156113",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "14"
                                },
                                "pagerange": {
                                    "@first": "1412",
                                    "@last": "1418"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.B.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Ma",
                                        "ce:indexed-name": "Ma B.B.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim W.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Goh",
                                        "ce:indexed-name": "Goh B.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Ma BBY, Lim WT, Goh BC, et al. Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the Mayo Clinic Phase 2 Consortium (NCI-9742). J Clin Oncol. 2018;36(14):1412-1418."
                    },
                    {
                        "ref-fulltext": "Wang, F.H., Wei, X.L., Feng, J., et al. Efficacy, safety, and correlative biomarkers of toripalimab in previously treated recurrent or metastatic nasopharyngeal carcinoma: a phase II clinical trial (POLARIS-02). J Clin Oncol 39:7 (2021), 704\u2013712.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Efficacy, safety, and correlative biomarkers of toripalimab in previously treated recurrent or metastatic nasopharyngeal carcinoma: a phase II clinical trial (POLARIS-02)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85102322448",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "39",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "704",
                                    "@last": "712"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang F.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "X.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wei",
                                        "ce:indexed-name": "Wei X.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Feng",
                                        "ce:indexed-name": "Feng J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Wang FH, Wei XL, Feng J, et al. Efficacy, safety, and correlative biomarkers of toripalimab in previously treated recurrent or metastatic nasopharyngeal carcinoma: a phase ii clinical trial (POLARIS-02). J Clin Oncol. 2021;39(7):704-712."
                    },
                    {
                        "ref-fulltext": "Fang, W., Yang, Y., Ma, Y., et al. Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials. Lancet Oncol 19:10 (2018), 1338\u20131350.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054779715",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1338",
                                    "@last": "1350"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Fang",
                                        "ce:indexed-name": "Fang W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Ma",
                                        "ce:indexed-name": "Ma Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Fang W, Yang Y, Ma Y, et al. Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials. Lancet Oncol. 2018;19(10):1338-1350."
                    },
                    {
                        "ref-fulltext": "Yang, Y., Qu, S., Li, J., et al. Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol 22 (2021), 1162\u20131174.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85110076251",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "1162",
                                    "@last": "1174"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Qu",
                                        "ce:indexed-name": "Qu S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Yang Y, Qu S, Li J, et al. Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2021;22:1162-1174."
                    },
                    {
                        "ref-fulltext": "Mai, H.Q., Chen, Q.Y., Chen, D., et al. Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial. Nat Med 27:9 (2021), 1536\u20131543.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85111855661",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1536",
                                    "@last": "1543"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Mai",
                                        "ce:indexed-name": "Mai H.Q."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Q.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen Q.Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Mai HQ, Chen QY, Chen D, et al. Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial. Nat Med. 2021;27(9):1536-1543."
                    },
                    {
                        "ref-fulltext": "Eisenhauer, E.A., Therasse, P., Bogaerts, J., et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:2 (2009), 228\u2013247.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "57849117384",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "45",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "228",
                                    "@last": "247"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Eisenhauer",
                                        "ce:indexed-name": "Eisenhauer E.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Therasse",
                                        "ce:indexed-name": "Therasse P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bogaerts",
                                        "ce:indexed-name": "Bogaerts J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247."
                    },
                    {
                        "ref-fulltext": "Chan, O.S., Kowanetz, M., Ng, W.T., et al. Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer. Oral Oncol 67 (2017), 52\u201360.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85012235753",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "52",
                                    "@last": "60"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "O.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan O.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kowanetz",
                                        "ce:indexed-name": "Kowanetz M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Ng",
                                        "ce:indexed-name": "Ng W.T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oral Oncol"
                        },
                        "ce:source-text": "Chan OS, Kowanetz M, Ng WT, et al. Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer. Oral Oncol. 2017;67:52-60."
                    },
                    {
                        "ref-fulltext": "Park, J.C., Durbeck, J., Boudadi, K., et al. The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma. Oral Oncol, 108, 2020, 104935.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "104935",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85089579262",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "108"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park J.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Durbeck",
                                        "ce:indexed-name": "Durbeck J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Boudadi",
                                        "ce:indexed-name": "Boudadi K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oral Oncol"
                        },
                        "ce:source-text": "Park JC, Durbeck J, Boudadi K, et al. The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma. Oral Oncol. 2020;108:104935."
                    },
                    {
                        "ref-fulltext": "Ma, B.B.Y., Hui, E.P., Chan, A.T.C., The expanding universe of checkpoint inhibitors for nasopharyngeal cancer. Nat Med 27:9 (2021), 1512\u20131513.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "The expanding universe of checkpoint inhibitors for nasopharyngeal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85115273726",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1512",
                                    "@last": "1513"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.B.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Ma",
                                    "ce:indexed-name": "Ma B.B.Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Hui",
                                    "ce:indexed-name": "Hui E.P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.T.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Chan",
                                    "ce:indexed-name": "Chan A.T.C."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Ma BBY, Hui EP, Chan ATC. The expanding universe of checkpoint inhibitors for nasopharyngeal cancer. Nat Med. 2021;27(9):1512-1513."
                    },
                    {
                        "ref-fulltext": "Even, C., Wang, H.-M., Li, S.-H., et al. Phase II, randomized study of spartalizumab (PDR001), an anti-PD-1 antibody, versus chemotherapy in patients with recurrent/metastatic nasopharyngeal cancer. Clin Cancer Res 27 (2021), 6413\u20136423.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Phase II, randomized study of spartalizumab (PDR001), an anti-PD-1 antibody, versus chemotherapy in patients with recurrent/metastatic nasopharyngeal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85120495726",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "6413",
                                    "@last": "6423"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Even",
                                        "ce:indexed-name": "Even C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.-M.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang H.-M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.-H.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li S.-H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Even C, Wang H-M, Li S-H, et al. Phase II, randomized study of spartalizumab (PDR001), an anti-PD-1 antibody, versus chemotherapy in patients with recurrent/metastatic nasopharyngeal cancer. Clin Cancer Res. 2021;27:6413-6423."
                    },
                    {
                        "ref-fulltext": "Delord, J.P., Hollebecque, A., De Boer, J.P., et al. An open-label, multicohort, phase I/II study to evaluate nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC). J Clin Oncol, 35(suppl 15), 2017 6025.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "An open-label, multicohort, phase I/II study to evaluate nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85026741511",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "35"}},
                            "ref-text": "6025",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Delord",
                                        "ce:indexed-name": "Delord J.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Hollebecque",
                                        "ce:indexed-name": "Hollebecque A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.P.",
                                        "@_fa": "true",
                                        "ce:surname": "De Boer",
                                        "ce:indexed-name": "De Boer J.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Delord JP, Hollebecque A, De Boer JP, et al. An open-label, multicohort, phase I/II study to evaluate nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC). J Clin Oncol. 2017;35(suppl 15):6025-6025."
                    },
                    {
                        "ref-fulltext": "Chan, A.T., Teo, P.M., Leung, T.W., et al. The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer 82:6 (1998), 1003\u20131012.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1998"},
                            "ref-title": {"ref-titletext": "The role of chemotherapy in the management of nasopharyngeal carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0032520781",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "82",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1003",
                                    "@last": "1012"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan A.T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Teo",
                                        "ce:indexed-name": "Teo P.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Leung",
                                        "ce:indexed-name": "Leung T.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer"
                        },
                        "ce:source-text": "Chan AT, Teo PM, Leung TW, et al. The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer. 1998;82(6):1003-1012."
                    },
                    {
                        "ref-fulltext": "Siu, L.L., Bauml, J., Adkins, D., et al. Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV+NPC). J Clin Oncol, 37(suppl 15), 2019, TPS6092.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV+NPC)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85147347034",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {"@first": "TPS6092"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Siu",
                                        "ce:indexed-name": "Siu L.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bauml",
                                        "ce:indexed-name": "Bauml J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Adkins",
                                        "ce:indexed-name": "Adkins D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Siu LL, Bauml J, Adkins D, et al. Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV+NPC). J Clin Oncol 2019;37(suppl 15):TPS6092."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kuching",
            "@id": "60090650",
            "affilname": "Hospital Umum Sarawak",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090650",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Tainan",
            "@id": "60073386",
            "affilname": "National Cheng Kung University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073386",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Manila",
            "@id": "60071488",
            "affilname": "University of Santo Tomas, Manila",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071488",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Goyang",
            "@id": "60068716",
            "affilname": "National Cancer Center, Gyeonggi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068716",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60031809",
            "affilname": "National Cancer Centre, Singapore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60029157",
            "affilname": "Universiti Malaya",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029157",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": null,
            "@id": "60024787",
            "affilname": "Prince of Wales Hospital Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024787",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "60023691",
            "affilname": "University of California, San Francisco",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023691",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60020857",
            "affilname": "Samsung Medical Center, Sungkyunkwan university",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020857",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60014234",
            "affilname": "Queen Elizabeth Hospital Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014234",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60013108",
            "affilname": "Princess Margaret Hospital Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013108",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60010400",
            "affilname": "Pantai Holdings Sdn Bhd",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010400",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Vancouver",
            "@id": "60010365",
            "affilname": "The University of British Columbia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010365",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Rahway",
            "@id": "60007995",
            "affilname": "Merck &amp; Co., Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007995",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Duarte",
            "@id": "60007474",
            "affilname": "City of Hope National Med Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007474",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60006541",
            "affilname": "The University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60006240",
            "affilname": "University of Ulsan College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "127780700",
            "affilname": "National University Cancer Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127780700",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "San Juan City",
            "@id": "126186367",
            "affilname": "Cardinal Santos Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126186367",
            "affiliation-country": "Philippines"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85147365199",
        "dc:description": "Background: Pembrolizumab previously demonstrated robust antitumor activity and manageable safety in a phase Ib study of patients with heavily pretreated, programmed death ligand 1 (PD-L1)-positive, recurrent or metastatic nasopharyngeal carcinoma (NPC). The phase III KEYNOTE-122 study was conducted to further evaluate pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent and/or metastatic NPC. Final analysis results are presented. Patients and methods: KEYNOTE-122 was an open-label, randomized study conducted at 29 sites, globally. Participants with platinum-pretreated recurrent and/or metastatic NPC were randomly assigned (1 : 1) to pembrolizumab or chemotherapy with capecitabine, gemcitabine, or docetaxel. Randomization was stratified by liver metastasis (present versus absent). The primary endpoint was overall survival (OS), analyzed in the intention-to-treat population using the stratified log-rank test (superiority threshold, one-sided P = 0.0187). Safety was assessed in the as-treated population. Results: Between 5 May 2016 and 28 May 2018, 233 participants were randomly assigned to treatment (pembrolizumab, n = 117; chemotherapy, n = 116); Most participants (86.7%) received study treatment in the second-line or later setting. Median time from randomization to data cut-off (30 November 2020) was 45.1 months (interquartile range, 39.0-48.8 months). Median OS was 17.2 months [95% confidence interval (CI) 11.7-22.9 months] with pembrolizumab and 15.3 months (95% CI 10.9-18.1 months) with chemotherapy [hazard ratio, 0.90 (95% CI 0.67-1.19; P = 0.2262)]. Grade 3-5 treatment-related adverse events occurred in 12 of 116 participants (10.3%) with pembrolizumab and 49 of 112 participants (43.8%) with chemotherapy. Three treatment-related deaths occurred: 1 participant (0.9%) with pembrolizumab (pneumonitis) and 2 (1.8%) with chemotherapy (pneumonia, intracranial hemorrhage). Conclusion: Pembrolizumab did not significantly improve OS compared with chemotherapy in participants with platinum-pretreated recurrent and/or metastatic NPC but did have manageable safety and a lower incidence of treatment-related adverse events.",
        "pubmed-id": "36535566",
        "prism:coverDate": "2023-03-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85147365199",
        "dc:creator": {"author": [{
            "preferred-name": {
                "ce:given-name": "A. T.C.",
                "ce:initials": "A.T.C.",
                "ce:surname": "Chan",
                "ce:indexed-name": "Chan A.T.C."
            },
            "@seq": "1",
            "ce:initials": "A.T.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60024787",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024787"
            },
            "ce:surname": "Chan",
            "@auid": "13404833700",
            "author-url": "https://api.elsevier.com/content/author/author_id/13404833700",
            "ce:indexed-name": "Chan A.T.C."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85147365199"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85147365199&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85147365199&origin=inward"
            }
        ],
        "source-id": "28711",
        "pii": "S0923753422047779",
        "citedby-count": "6",
        "prism:volume": "34",
        "subtype": "ar",
        "dc:title": "Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial",
        "openaccess": "1",
        "prism:issn": "15698041 09237534",
        "publishercopyright": "© 2023 Merck Sharp & Dohme LLC., a subsidiary Merck & Co., Inc., The Author(s).",
        "prism:issueIdentifier": "3",
        "subtypeDescription": "Article",
        "prism:publicationName": "Annals of Oncology",
        "prism:pageRange": "251-261",
        "prism:endingPage": "261",
        "openaccessFlag": "true",
        "prism:doi": "10.1016/j.annonc.2022.12.007",
        "prism:startingPage": "251",
        "dc:identifier": "SCOPUS_ID:85147365199",
        "dc:publisher": "Elsevier Ltd"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Antibodies, Monoclonal, Humanized",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antineoplastic Combined Chemotherapy Protocols",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Docetaxel",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Nasopharyngeal Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Platinum",
            "@weight": "a",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "immunotherapy"
        },
        {
            "@_fa": "true",
            "$": "nasopharyngeal cancer"
        },
        {
            "@_fa": "true",
            "$": "pembrolizumab"
        },
        {
            "@_fa": "true",
            "$": "programmed death-1 (PD-1)"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "preferred-name": {
                "ce:given-name": "A. T.C.",
                "ce:initials": "A.T.C.",
                "ce:surname": "Chan",
                "ce:indexed-name": "Chan A.T.C."
            },
            "@seq": "1",
            "ce:initials": "A.T.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60024787",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024787"
            },
            "ce:surname": "Chan",
            "@auid": "13404833700",
            "author-url": "https://api.elsevier.com/content/author/author_id/13404833700",
            "ce:indexed-name": "Chan A.T.C."
        },
        {
            "preferred-name": {
                "ce:given-name": "V. H.F.",
                "ce:initials": "V.H.F.",
                "ce:surname": "Lee",
                "ce:indexed-name": "Lee V.H.F."
            },
            "@seq": "2",
            "ce:initials": "V.H.F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006541",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541"
            },
            "ce:surname": "Lee",
            "@auid": "57209197322",
            "author-url": "https://api.elsevier.com/content/author/author_id/57209197322",
            "ce:indexed-name": "Lee V.H.F."
        },
        {
            "preferred-name": {
                "ce:given-name": "R. L.",
                "ce:initials": "R.L.",
                "ce:surname": "Hong",
                "ce:indexed-name": "Hong R.L."
            },
            "@seq": "3",
            "ce:initials": "R.-L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073385",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385"
            },
            "ce:surname": "Hong",
            "@auid": "57223631236",
            "author-url": "https://api.elsevier.com/content/author/author_id/57223631236",
            "ce:indexed-name": "Hong R.-L."
        },
        {
            "preferred-name": {
                "ce:given-name": "M. J.",
                "ce:initials": "M.J.",
                "ce:surname": "Ahn",
                "ce:indexed-name": "Ahn M.J."
            },
            "@seq": "4",
            "ce:initials": "M.-J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60020857",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020857"
            },
            "ce:surname": "Ahn",
            "@auid": "7103352186",
            "author-url": "https://api.elsevier.com/content/author/author_id/7103352186",
            "ce:indexed-name": "Ahn M.-J."
        },
        {
            "preferred-name": {
                "ce:given-name": "W. Q.",
                "ce:initials": "W.Q.",
                "ce:surname": "Chong",
                "ce:indexed-name": "Chong W.Q."
            },
            "@seq": "5",
            "ce:initials": "W.Q.",
            "@_fa": "true",
            "affiliation": {
                "@id": "127780700",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127780700"
            },
            "ce:surname": "Chong",
            "@auid": "57217144745",
            "author-url": "https://api.elsevier.com/content/author/author_id/57217144745",
            "ce:indexed-name": "Chong W.Q."
        },
        {
            "preferred-name": {
                "ce:given-name": "S. B.",
                "ce:initials": "S.B.",
                "ce:surname": "Kim",
                "ce:indexed-name": "Kim S.B."
            },
            "@seq": "6",
            "ce:initials": "S.-B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006240",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240"
            },
            "ce:surname": "Kim",
            "@auid": "34770722200",
            "author-url": "https://api.elsevier.com/content/author/author_id/34770722200",
            "ce:indexed-name": "Kim S.-B."
        },
        {
            "preferred-name": {
                "ce:given-name": "G. F.",
                "ce:initials": "G.F.",
                "ce:surname": "Ho",
                "ce:indexed-name": "Ho G.F."
            },
            "@seq": "7",
            "ce:initials": "G.F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60029157",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029157"
            },
            "ce:surname": "Ho",
            "@auid": "55009123200",
            "author-url": "https://api.elsevier.com/content/author/author_id/55009123200",
            "ce:indexed-name": "Ho G.F."
        },
        {
            "preferred-name": {
                "ce:given-name": "P. B.",
                "ce:initials": "P.B.",
                "ce:surname": "Caguioa",
                "ce:indexed-name": "Caguioa P.B."
            },
            "@seq": "8",
            "ce:initials": "P.B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60071488",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071488"
            },
            "ce:surname": "Caguioa",
            "@auid": "6506598676",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506598676",
            "ce:indexed-name": "Caguioa P.B."
        },
        {
            "preferred-name": {
                "ce:given-name": "N.",
                "ce:initials": "N.",
                "ce:surname": "Ngamphaiboon",
                "ce:indexed-name": "Ngamphaiboon N."
            },
            "@seq": "9",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:surname": "Ngamphaiboon",
            "@auid": "35435598900",
            "author-url": "https://api.elsevier.com/content/author/author_id/35435598900",
            "ce:indexed-name": "Ngamphaiboon N."
        },
        {
            "preferred-name": {
                "ce:given-name": "C.",
                "ce:initials": "C.",
                "ce:surname": "Ho",
                "ce:indexed-name": "Ho C."
            },
            "@seq": "10",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010365",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010365"
            },
            "ce:surname": "Ho",
            "@auid": "57984513700",
            "author-url": "https://api.elsevier.com/content/author/author_id/57984513700",
            "ce:indexed-name": "Ho C."
        },
        {
            "preferred-name": {
                "ce:given-name": "M. A.S.A.",
                "ce:initials": "M.A.S.A.",
                "ce:surname": "Aziz",
                "ce:indexed-name": "Aziz M.A.S.A."
            },
            "@seq": "11",
            "ce:initials": "M.A.S.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010400",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010400"
            },
            "ce:surname": "Aziz",
            "@auid": "58090215100",
            "author-url": "https://api.elsevier.com/content/author/author_id/58090215100",
            "ce:indexed-name": "Aziz M.A.S.A."
        },
        {
            "preferred-name": {
                "ce:given-name": "Q. S.",
                "ce:initials": "Q.S.",
                "ce:surname": "Ng",
                "ce:indexed-name": "Ng Q.S."
            },
            "@seq": "12",
            "ce:initials": "Q.S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031809",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809"
            },
            "ce:surname": "Ng",
            "@auid": "13104423000",
            "author-url": "https://api.elsevier.com/content/author/author_id/13104423000",
            "ce:indexed-name": "Ng Q.S."
        },
        {
            "preferred-name": {
                "ce:given-name": "C. J.",
                "ce:initials": "C.J.",
                "ce:surname": "Yen",
                "ce:indexed-name": "Yen C.J."
            },
            "@seq": "13",
            "ce:initials": "C.-J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073386",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073386"
            },
            "ce:surname": "Yen",
            "@auid": "58089961000",
            "author-url": "https://api.elsevier.com/content/author/author_id/58089961000",
            "ce:indexed-name": "Yen C.-J."
        },
        {
            "preferred-name": {
                "ce:given-name": "N.",
                "ce:initials": "N.",
                "ce:surname": "Soparattanapaisarn",
                "ce:indexed-name": "Soparattanapaisarn N."
            },
            "@seq": "14",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199575",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"
            },
            "ce:surname": "Soparattanapaisarn",
            "@auid": "37102561700",
            "author-url": "https://api.elsevier.com/content/author/author_id/37102561700",
            "ce:indexed-name": "Soparattanapaisarn N."
        },
        {
            "preferred-name": {
                "ce:given-name": "R. K.C.",
                "ce:initials": "R.K.C.",
                "ce:surname": "Ngan",
                "ce:indexed-name": "Ngan R.K.C."
            },
            "@seq": "15",
            "ce:initials": "R.K.-C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60014234",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014234"
            },
            "ce:surname": "Ngan",
            "@auid": "57222641833",
            "author-url": "https://api.elsevier.com/content/author/author_id/57222641833",
            "ce:indexed-name": "Ngan R.K.-C."
        },
        {
            "preferred-name": {
                "ce:given-name": "S. K.",
                "ce:initials": "S.K.",
                "ce:surname": "Kho",
                "ce:indexed-name": "Kho S.K."
            },
            "@seq": "16",
            "ce:initials": "S.K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60090650",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090650"
            },
            "ce:surname": "Kho",
            "@auid": "57221906319",
            "author-url": "https://api.elsevier.com/content/author/author_id/57221906319",
            "ce:indexed-name": "Kho S.K."
        },
        {
            "preferred-name": {
                "ce:given-name": "M. L.A.",
                "ce:initials": "M.L.A.",
                "ce:surname": "Tiambeng",
                "ce:indexed-name": "Tiambeng M.L.A."
            },
            "@seq": "17",
            "ce:initials": "M.L.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126186367",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126186367"
            },
            "ce:surname": "Tiambeng",
            "@auid": "57193519025",
            "author-url": "https://api.elsevier.com/content/author/author_id/57193519025",
            "ce:indexed-name": "Tiambeng M.L.A."
        },
        {
            "preferred-name": {
                "ce:given-name": "T.",
                "ce:initials": "T.",
                "ce:surname": "Yun",
                "ce:indexed-name": "Yun T."
            },
            "@seq": "18",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60068716",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068716"
            },
            "ce:surname": "Yun",
            "@auid": "7005281991",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005281991",
            "ce:indexed-name": "Yun T."
        },
        {
            "preferred-name": {
                "ce:given-name": "V.",
                "ce:initials": "V.",
                "ce:surname": "Sriuranpong",
                "ce:indexed-name": "Sriuranpong V."
            },
            "@seq": "19",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Sriuranpong",
            "@auid": "6603599644",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603599644",
            "ce:indexed-name": "Sriuranpong V."
        },
        {
            "preferred-name": {
                "ce:given-name": "A. P.",
                "ce:initials": "A.P.",
                "ce:surname": "Algazi",
                "ce:indexed-name": "Algazi A.P."
            },
            "@seq": "20",
            "ce:initials": "A.P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60023691",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023691"
            },
            "ce:surname": "Algazi",
            "@auid": "36943945300",
            "author-url": "https://api.elsevier.com/content/author/author_id/36943945300",
            "ce:indexed-name": "Algazi A.P."
        },
        {
            "preferred-name": {
                "ce:given-name": "A.",
                "ce:initials": "A.",
                "ce:surname": "Cheng",
                "ce:indexed-name": "Cheng A."
            },
            "@seq": "21",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60013108",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013108"
            },
            "ce:surname": "Cheng",
            "@auid": "36055097300",
            "author-url": "https://api.elsevier.com/content/author/author_id/36055097300",
            "ce:indexed-name": "Cheng A."
        },
        {
            "preferred-name": {
                "ce:given-name": "E.",
                "ce:initials": "E.",
                "ce:surname": "Massarelli",
                "ce:indexed-name": "Massarelli E."
            },
            "@seq": "22",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60007474",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007474"
            },
            "ce:surname": "Massarelli",
            "@auid": "6602382732",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602382732",
            "ce:indexed-name": "Massarelli E."
        },
        {
            "preferred-name": {
                "ce:given-name": "R. F.",
                "ce:initials": "R.F.",
                "ce:surname": "Swaby",
                "ce:indexed-name": "Swaby R.F."
            },
            "@seq": "23",
            "ce:initials": "R.F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60007995",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007995"
            },
            "ce:surname": "Swaby",
            "@auid": "8908060000",
            "author-url": "https://api.elsevier.com/content/author/author_id/8908060000",
            "ce:indexed-name": "Swaby R.F."
        },
        {
            "preferred-name": {
                "ce:given-name": "S.",
                "ce:initials": "S.",
                "ce:surname": "Saraf",
                "ce:indexed-name": "Saraf S."
            },
            "@seq": "24",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60007995",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007995"
            },
            "ce:surname": "Saraf",
            "@auid": "57192942563",
            "author-url": "https://api.elsevier.com/content/author/author_id/57192942563",
            "ce:indexed-name": "Saraf S."
        },
        {
            "preferred-name": {
                "ce:given-name": "J.",
                "ce:initials": "J.",
                "ce:surname": "Yuan",
                "ce:indexed-name": "Yuan J."
            },
            "@seq": "25",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60007995",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007995"
            },
            "ce:surname": "Yuan",
            "@auid": "58089961300",
            "author-url": "https://api.elsevier.com/content/author/author_id/58089961300",
            "ce:indexed-name": "Yuan J."
        },
        {
            "preferred-name": {
                "ce:given-name": "L. L.",
                "ce:initials": "L.L.",
                "ce:surname": "Siu",
                "ce:indexed-name": "Siu L.L."
            },
            "@seq": "26",
            "ce:initials": "L.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016849",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849"
            },
            "ce:surname": "Siu",
            "@auid": "7006651151",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006651151",
            "ce:indexed-name": "Siu L.L."
        }
    ]}
}}